Thank you. So much wisdom in your post. One thing I am not

New Post Public Reply Private Reply Replies (0) Message Board
patientgal Shuler #3427
Thank you. So much wisdom in your post.

One thing I am not concerned with is the treatments; I am not concerned about the time it may take to complete the additional experiments (whatever they may be) or any additional information the FDA has requested the company provide to validate the safety, efficacy & ownership of HemaXellerate. It is still my firm belief that the extent of the present delays go back to the Oregon State mishap as well as the fact that when HemaXellerate emerges finally, it will emerge with Orphan Drug status. I don't believe there will be an additional wait period for this. I believe when approval is at last announced, it will be so with Orphan Drug status.

I absolutely have 100% faith in the medicine and the doctor's creating it. Their reputations, discoveries and work history speak volumes.

When I discovered the major muck up by Oregon State and subsequently alerted the company to it (yes, that was me) judging by the amount of time it took for the USPTO to update the expiration coupled with knowing how the FDA works, I suspected there would be some major changes in the already processed paperwork. Nothing I found indicated that the application consideration would be halted pending these modifications. At least not in terms of evaluating the treatment...not the empirical data, legitimacy, etc., etc., And even after communicating with several lawyers and people in-the-know within pharma & regulations, I still do not know as the consensus is the level of difficulty will be dictated by the person in charge of the case. Protocol or no protocol, much depends on the person whose lap this submission fell in. That is government for you.

My concern now is Koos. To answer a great number of email and PM's: in short, yes, I am pissed, to some extent I feel used and over the past couple of days I have said to myself "what a dumb ass you are!" as I read through file after file after file of information relating to Koos. Yup, I married the science and neglected to thoroughly vet the in-law before doing so.

See, my problem is I have difficulty in wrapping my head around good people being intimately aligned with a POS. Sure, we all have some indirect connection with someone who is absolutely no good. But, as a person who is the antithesis to most things considered commonplace now (i.e., corruption, apathy, laziness, greed, etc., etc.,) I find it very hard to accept that a truly decent person (or people) can be aligned with people (or a person) whose aim is to inflict harm. The moment I figure out that someone who has entered my life is nothing but bad, I do all I can to rid myself of that person. I don't want to be at risk of being personally damaged nor do I want the guilt my association looming over my head. Ridding myself of such is not always an easy task however. So, discovering what I did about the doctors (professionally and personally) it never dawned on me that Koos would willfully function in a capacity that is so contrary to the doctors that essentially, he depends on. (Yeah, yeah, I know.)


I digress... as I have already pointed out, much of what I have read over the past several days has left me with a very bitter taste. I have even found myself going to Yahoo message boards to read the history of posts by that seemingly insane Joe_from_Weymouth poster. Though I am pretty sure he posts on iHub, he says much more on the Yahoo board since the posters have a great deal more latitude there. From what I have read thus far, do I think Dr. Ichim, Dr. Min, Dr. Suhy & Benitec have had any idea of what Koos has been up to in his past? Nope. Absolutely not!  Do I think Koos's shareholders have been a main concern of his in the past? Nope. Do I think that some of the very bad BMSN/ENTB financial decisions (i.e., Asher/Southridge) that he has made were done out of ignorance? Nope. Do I think that up until very recently there was a whole lot of wool being pulled over our eyes? Yup! Do I think that I am going to sit back and do nothing while I am royally screwed out of my money and treated with an inexplicable disregard? Nope!!!

What that means I don't know just yet. I am working on that one.

That is where I am with this presently as I continue to dig. Try to have a good weekend, most.


RIVULET MEDIA INC. (RIVU) Stock Research Links

RIVU Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Taiwan's Bold Bid: From Tech Hub to Capital Magnet

Updated Category News Views 100

Ambitious Plans Unveiled at Taiwan Weeks 2026 Forget the usual humdrum; Taiwan’s pulling no punches in its bid to become a capital powerhouse in Asia. If you'd told me years ago that Taiwan was eyeing dominance in asset management, I might've laughed. But at the 2026 Taiwan Weeks, they showed they're dead serious about it. Over 400 bigwigs and market shakers gathered,...

Continue Reading
Telix Boosts Theranostic Reach with Thera4Care Move

Updated Category News Views 74

Telix's Strategic Move into Theranostics Investing in cancer treatment isn't all about playing defense. Sometimes it's about taking a swing at the next big thing in theranostics. Telix Pharmaceuticals (ASX: TLX, NASDAQ: TLX) has hitched its wagon to the Thera4Care initiative, pushing for a serious expansion of their presence in the European medical field. It's all about...

Continue Reading
GomSpace Targets SEK 1.6 Billion Revenue by 2030

Updated Category News Views 113

GomSpace's Bold Ambition for 2030 The small satellite sector just got a wake-up call from GomSpace. This company has its eyes locked on a jaw-dropping SEK 1.6 billion in revenue by 2030. That's not just some pie-in-the-sky dream. GomSpace is gunning for a calculated annual growth of 30%, riding high on revamped operations and a mighty push into big, juicy contract...

Continue Reading
Citius Unveils Promising LYMPHIR Data at EORTC Conference

Updated Category News Views 84

A Closer Look at LYMPHIR's Impact on CTCL Patients Well, here's a whiff of genuine hope for folks grappling with relapsed or refractory cutaneous T-cell lymphoma (CTCL). Coming out of New Jersey, Citius Oncology has dished out some pretty promising news, fresh from the European Organisation for Research and Treatment of Cancer Cutaneous Lymphoma Tumour Group's annual...

Continue Reading
Unum Group Faces Investigation Amid $419.7M Net Loss

Updated Category News Views 61

Troubling Times for Unum Group Investors Alright, folks, let’s get down to brass tacks: Unum Group (NYSE: UNM) is swimming upstream, and not in any leisurely, salmon-like sense. Their third-quarter report revealed a whopping $419.7 million net loss—something that can unsettle even the steadiest ship in the murky waters of the market. Pair that with an SEC...

Continue Reading
BD Appoints Bagnato as Peripheral Intervention Head

Updated Category News Views 86

A New Captain for BD's Peripheral Ship Time to pay attention, folks. Franklin Lakes just sent an interesting ripple through their workforce headlines, announcing Bridget Bagnato taking the reins as Worldwide President of BD's Peripheral Intervention division. Come November 16, this medical tech veteran, who's clocked over 27 years with BD, is set to start steering their...

Continue Reading
Brightstar's iCAP Ready Badge: A Gamble on Responsibility

Updated Category News Views 334

Another Feather in Brightstar's Cap You might not toss 'responsible gaming standards' around in casual talk, but in the gaming biz, it's a badge of honor. Brightstar Lottery PLC (NYSE: BRSL) ain't just spinning wheels here—they've got themselves re-accredited with iCAP Ready from the National Council on Problem Gambling (NCPG). It's the stamp of approval that shows...

Continue Reading
Adient Boosts Buyback, Shields Valuable Tax Assets

Updated Category News Views 47

Adient's Aggressive Buyback and Tax Strategy Well, it looks like Adient's not just sitting on its hands. They've not only opened up the cash taps with a $400 million increase in their share repurchase authorization but also shored up their defenses with a Tax Benefits Preservation Plan. You know, when a company dishes out that kind of cash, it tells you they see some...

Continue Reading
Dircks Expands with Major Phoenix Lease Deal

Updated Category News Views 67

Another Big Win in Phoenix's Industrial Space Who'd have thought? Dircks Moving & Logistics just bagged themselves a hefty 337,897-square-foot lease in Phoenix. This isn’t just any warehouse deal in the Southwest Valley—it’s a mark of where the industrial real estate world’s trending these days. For those who watch these things, they’ve pushed their local space...

Continue Reading
Youdao's Upcoming Q3 2026 Results: What's at Stake?

Updated Category News Views 47

Anticipation Builds Ahead of Youdao's Financial Announcement Okay, folks, if there's one thing investors gotta mark on their calendars, it's Youdao’s upcoming financial results set to drop like a bombshell on November 19, 2026. This ain't just another quarterly report—it's a litmus test for anyone eyeballing the digital learning sector with wallets ready. Youdao: A...

Continue Reading

Top 5 Most Recently Viewed Articles

Dow Inc. Shares Faces Shareholder Class Action Opportunity

Updated Category News Views 291

Investors Affected by Dow Inc.'s Stock Performance Recently, Dow Inc. has encountered significant challenges affecting its stock performance, raising concerns among investors. Those who acquired shares of Dow Inc. (NYSE: DOW) are now presented with an opportunity to lead a shareholder class action lawsuit. This legal action concerns claims against Dow and its executives...

Continue Reading
Northwest Bank's Recognition Illuminates Strategic Strengths

Updated Category News Views 17

A Meaningful Milestone in Northwest Bank's Journey Not every day you hear about a regional player like Northwest Bank cutting through the noise to land on TIME's list of America’s Best Companies. Clocking in at #394 out of 1,000, they seem to be doing something right among the jackals of Wall Street. Folks, they didn't just get there on blind luck—Northwest clawed its...

Continue Reading
Ameren Corporation Launches New Stock Offering Initiative

Updated Category News Views 308

Ameren Corporation Unveils New Stock Offering In a strategic move to bolster its financial position, Ameren Corporation (NYSE: AEE) has announced the pricing of a significant underwritten offering of common stock. The company is set to offer 5,550,416 shares at an attractive public price of $94.00 each. This offering is aimed at facilitating various corporate financial...

Continue Reading
Insights into Nike's Recent Market Movements and Trends

Updated Category News Views 262

Current Market Sentiment on Nike Nike (NKE) has recently seen an increase in its short interest, with a reported 23.96% rise since the last assessment. Currently, there are 44.81 million shares sold short, constituting 4.76% of the company’s total available shares for trading. In the context of trading volume, it is estimated that it would take approximately 1.55 days...

Continue Reading
Investigation Launched into OSI Systems, Inc. Security Practices

Updated Category News Views 165

Investigation into OSI Systems, Inc. by Pomerantz LLP Pomerantz LLP has launched a thorough investigation into the practices of OSI Systems, Inc. (NASDAQ: OSIS) following concerning claims made by investors. The firm is dedicated to uncovering the truth about potential securities violations that may have impacted the company's stakeholders. Allegations of Fraud and...

Continue Reading